Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	71.62	-4813.26	-16957.53
Graham Fair Price	-20.16	7.56	9.47
PEG	-732.47	-13.45	-1.62
Price/Book	15.18	13.40	11.63
Price/Cash Flow	-15.81	167.92	199.45
Prices/Earnings	98.21	512.44	258.54
Price/Sales	22.52	50.61	41.31
Price/FCF	-15.81	167.92	199.45
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.64	0.81	0.83
Operating Margin	-36.33	-0.03	-0.02
ROA	-39.36	< 0.005	< 0.005
ROE	0.01	< 0.005	-41.89
ROIC	< 0.005	< 0.005	-56.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.05	0.05	-9.74
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.82	-0.35	-56.69
EPS QOQ	1.60	-0.38	-76.19
FCF QOQ	2.39	0.45	-81.39
Revenue QOQ	0.17	< 0.005	-95.82
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-10.78
Days Sales Outstanding (DSO)	75.22	56.59	-24.76
Inventory Turnover	37949000.00	42533000.00	12.08
Debt/Capitalization	0.43	0.41	-5.94
Quick Ratio	1.05	1.11	5.37
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.83	19.73	4.73
Cash	23.61	25.42	7.64
Capex	-0.02	-0.04	-166.06
Free Cash Flow	1.10	1.57	43.29
Revenue	5.30	5.22	-1.54
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.08	1.14	5.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-442.54	-56.24	87.29
Naive Interpretation	Member

06 - Financial Health · Bad

Rating